Bioavailability enhancement

AI in pharmaceutical drug product design is, in 2026, a decision-support technology, not autonomous formulation. The most mature tools combine...

Amphiphilic, non-ionic block copolymers suitable for diverse pharmaceutical applications Did you know? Kolliphor® P grade poloxamers are among the most...

Abstract Biomacromolecules including peptides, proteins, antibodies, and gene medicines, comprise important classes of therapeutics in treating disease. A drawback of...

Abstract The anti-glaucoma drug betaxolol hydrochloride (BH) exhibits poor ocular bioavailability due to limited corneal permeability, rapid precorneal loss, short...

Abstract This study aims to develop the freeze-dried core–shell nanoparticles (nanocapsules; NCs) as an effective dosage form for improving the...

Abstract In this research, with the aim of improving the solubility and bioavailability of famotidine, the inclusion complex of famotidine...

Abstract As global public health issue, osteoporosis (OP) has been conventionally managed with osteoanabolic/antiresorptive drugs with side effect. Recently, collagen...

Abstract A gastro-retentive drug delivery system based on a tablet-integrated superporous hydrogel (SPH) was developed using Famotidine as a model...

This poster has been presented at the 2026 World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology. Introduction Fused Deposition...

Abstract Purpose Cabazitaxel (CBZ) is a semi-synthetic anti-cancer drug and belongs to BCS class IV category with poor water solubility...